Can molotinib/mometinib be purchased in China? Is there a domestic version?

As of April 2025, Momelotinib/Momelotinib has not yet been officially launched in the Chinese market, so it cannot be purchased directly in the country for the time being, nor can it be included in medical insurance. For patients suffering from diseases such as myelofibrosis (MF), they cannot obtain the imported version or domestic generic version of the drug in China. Currently, the original drug version of molotinib is available in other parts of the world, and patients need to purchase the drug through overseas channels.

In overseas markets, both the original drug and generic drugs of molotinib are available for purchase, and the ingredients and specifications of the two are basically the same. Common specifications of original drugs include 100mg 30 tablets, 150mg 30 tablets and 200mg*30 tablets. The price is relatively high. The price of each box of original drugs may be close to 200,000 yuan (the specific price will change due to exchange rate fluctuations). Because original drugs are relatively expensive, many patients may not be able to afford their high cost.

In comparison, the price of generic versions produced by drug manufacturers in countries such as Laos is relatively low. The price of generic drugs100mg*30 tablets per box is about more than 2,000 yuan. Although the price fluctuates due to exchange rates, it is still far lower than the price of the original drug. Therefore, many patients choose to purchase generic drugs through overseas channels, which provides them with a more economical treatment option.

However, since there is currently no imported or domestic generic version of molotinib in China, patients who need the drug can only purchase it through legal overseas channels. These channels include international drug purchasing agents, cross-border e-commerce platforms, and overseas procurement services of some medical institutions. However, when purchasing, special attention needs to be paid to the authenticity, source, and formality of transportation channels to ensure that you are purchasing qualified drugs.

In summary, although molotinib is currently unavailable in the Chinese market, patients can still obtain the drug through overseas channels. In particular, generic drugs are a relatively affordable option and can provide a more feasible solution for patients in need of treatment.

Reference materials:https://en.wikipedia.org/wiki/Momelotinib